We are live on
!
Find out more
TRIM
Thompson Rubinstein Investment Management Portfolio holdings
AUM
$311M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$14.7M
(+5.9%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
38.1%
Holding
71
New
3
Increased
13
Reduced
22
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.93M |
| 2 |
DNOW Inc
DNOW
|
+$661K |
| 3 |
Pfizer
PFE
|
+$280K |
| 4 |
Leggett & Platt
LEG
|
+$200K |
| 5 |
DO
Diamond Offshore Drilling
DO
|
+$95.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NOV
NOV
|
+$624K |
| 2 |
SVU
SUPERVALU Inc.
SVU
|
+$444K |
| 3 |
Automatic Data Processing
ADP
|
+$206K |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$77.5K |
| 5 |
Intel
INTC
|
+$71.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.49% |
| 2 | Healthcare | 22.38% |
| 3 | Energy | 20.31% |
| 4 | Technology | 14.32% |
| 5 | Consumer Staples | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
US Bancorp
USB
$99.6B
| $1.39M | 0.52% |
32,086
| – | – |
|
|
LVLT
52
DELISTED
Level 3 Communications Inc
LVLT
| $1.31M | 0.49% |
29,838
-113
| -0.4% | -$4.74K |
|
|
QEP
53
DELISTED
QEP RESOURCES, INC.
QEP
| $1.21M | 0.46% |
35,000
-270
| -0.8% | -$8.54K |
|
54
AT&T
T
$163B
| $916K | 0.35% |
34,314
-530
| -2% | -$14.2K |
|
|
STR
55
DELISTED
QUESTAR CORP
STR
| $875K | 0.33% |
35,270
| – | – |
|
56
Merck
MRK
$318B
| $801K | 0.3% |
14,519
+105
| +0.7% | +$5.73K |
|
57
Kemper
KMPR
$1.68B
| $783K | 0.3% |
21,253
+350
| +2% | +$13K |
|
58
IBM
IBM
$224B
| $761K | 0.29% |
4,389
+152
| +4% | +$27.4K |
|
59
Travelers Companies
TRV
$80.2B
| $715K | 0.27% |
7,597
| – | – |
|
|
60
DNOW Inc
DNOW
$3.02B
| $695K | 0.26% |
+19,202
| New | +$661K |
|
61
Johnson Controls International
JCI
$92.2B
| $683K | 0.26% |
13,064
| – | – |
|
62
JPMorgan Chase
JPM
$950B
| $515K | 0.19% |
8,945
-123
| -1% | -$6.92K |
|
63
Bristol-Myers Squibb
BMY
$132B
| $466K | 0.18% |
9,600
| – | – |
|
|
MRSH
64
Marsh
MRSH
$91.5B
| $401K | 0.15% |
7,730
| – | – |
|
65
Verizon
VZ
$196B
| $382K | 0.14% |
7,817
-50
| -0.6% | -$2.42K |
|
66
RTX Corp
RTX
$301B
| $369K | 0.14% |
5,085
| – | – |
|
67
Oracle
ORCL
$423B
| $320K | 0.12% |
7,900
| – | – |
|
68
ING
ING
$102B
| $286K | 0.11% |
20,388
| – | – |
|
69
Cabot Corp
CBT
$4.52B
| $278K | 0.1% |
4,800
| – | – |
|
70
SPX Corp
SPXC
$10.8B
| $229K | 0.09% |
8,415
| – | – |
|
|
71
Leggett & Platt
LEG
$1.31B
| $206K | 0.08% |
+6,000
| New | +$200K |
|
Similar funds
CFS
SVWA
SAS
LYV
TAT
NAP
OAMU
TCM
Thompson Rubinstein Investment Management's Q2 2014 Portfolio in Review
As of Q2 2014, Thompson Rubinstein Investment Management held 71 positions worth $265M, up 5.9% from $250M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.2%. Thompson Rubinstein Investment Management opened 3 new positions and made no exits, leaving the 71-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Energy.
- Thompson Rubinstein Investment Management's largest Q2 2014 buy was AbbVie: 36,831 shares worth $2.08M.
- Thompson Rubinstein Investment Management added most to Pfizer in Q2 2014, an estimated $280K increase.
- Thompson Rubinstein Investment Management's biggest Q2 2014 reduction was NOV, cutting an estimated $624K.
- Thompson Rubinstein Investment Management's ten largest holdings make up 38% of its $265M portfolio in Q2 2014.
- Thompson Rubinstein Investment Management opened 3 new positions and closed 0 in Q2 2014.
- Thompson Rubinstein Investment Management's portfolio value rose 5.9% quarter-over-quarter to $265M.
Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2014, filed 10 Jul 2014.